+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis



Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis



Carcinogenesis 26(3): 525-530



Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are important in regulating the development, growth and differentiation of cells and have inhibitory effects on non-small cell lung cancer (NSCLC) cell growth. A comprehensive analysis of all RAR and RXR subtypes mRNA expression in a large series of patients with NSCLC and their role in the development and progression of this disease is lacking. Using a quantitative real-time RT-PCR method, we analyzed the mRNA expression of all retinoid receptor subtypes in tumor and matching normal-appearing tissues of 88 patients with NSCLC. Gene expression in tumor tissues was detected with the following frequencies: RARalpha 100%, RARbeta 94%, RARgamma 94%, RXRalpha 100%, RXRbeta 100% and RXRgamma 92%. Levels of mRNA expression in tumor tissues compared with matching normal-appearing tissue were equal or reduced with the following frequencies: RARalpha 76.1%, RARbeta 59.1%, RARgamma 39.8%, RXRalpha 67.1%, RXRbeta 54.5% and RXRgamma 88.6%, and were significantly associated with any one other subtype. The probability of survival was significantly different among patients with low gene expression in no or any two subtypes, any three or four subtypes or any five or six subtypes (P = 0.004, log rank test). Multivariate analysis confirmed low gene expression status as a significant independent unfavorable prognostic factor (P = 0.015). Our results show that decreased expression of all RAR and RXR receptor subtypes is a frequent event in NSCLC. Widely co-regulated down-regulation of expression of all retinoid subclasses suggests a fundamental dysregulation of the retinoid pathway in this cancer. Quantitation of RAR and RXR mRNA expression levels in tumor tissue is a candidate prognostic marker and surrogate biomarker for chemopreventive trials in NSCLC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004084986

Download citation: RISBibTeXText

PMID: 15618235

DOI: 10.1093/carcin/bgi006


Related references

Multiple retinoid-responsive receptors in a single cell: families of retinoid "X" receptors and retinoic acid receptors in the Xenopus egg. Proceedings of the National Academy of Sciences of the United States of America 89(6): 2321-2325, 1992

Retinoic acid nuclear receptors and retinoid X receptors gene expression in estrogen receptor positive and negative breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 35: 274, 1994

Retinoid activation of retinoic acid receptors but not retinoid X receptors is sufficient for mouse embryonic development. FASEB Journal 17(4-5): Abstract No 468 12, 2003

Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Oncogene 17(22): 2839-2849, 1998

Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma. Cancer Research 61(2): 556-564, 2001

Cell-specific transactivation of naturally occurring retinoid-responsive genes by nuclear retinoic acid receptors and retinoid X receptors in human keratinocytes and CV1 cells. Journal of Investigative Dermatology 100(4): 499, 1993

Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. Journal of Translational Medicine 11: 102, 2013

Differential expression of retinoid acid receptors in non-small cell lung carcinomas and in bronchial epithelia. Proceedings of the American Association for Cancer Research Annual Meeting 36: 601, 1995

Selective alterations in expression of retinoid-responsive genes may be mediated by changes in DNA binding and transcriptional activity of retinoid receptors in APL cell lines selected for resistance to retinoic acid. Blood 86(10 Suppl. 1): 170A, 1995

Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. International Journal of Cancer 78(2): 248-254, 1998

Expression of retinoid-X receptors and retinoic acid receptors in normal human skin An immunohistological evaluation. Histochemical Journal 29(2): 127-133, 1997

Expression of retinoic acid receptors and retinoid X receptors in normal and vitamin A deficient adult rat brain. Annals of Anatomy 195(2): 111-121, 2013

Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Research 55(13): 2774-2782, 1995

Retinoic acid stimulation of the growth of CALU-1 human lung cancer cell line in serum-free medium is associated with increased AP-1 activity and not with activation of nuclear retinoid receptors. Proceedings of the American Association for Cancer Research Annual Meeting 37: 232, 1996

Oestrogen and progesterone do not regulate the expression of retinoic acid receptors and retinoid 'X' receptors in human endometrial stromal cells in vitro. Human Reproduction 9(2): 229-234, 1994